• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制患者的良性淋巴组织增生性疾病:最新进展。

Benign lymphoproliferative disorders in the immunosuppressed patient: an update.

机构信息

Department of Oral Biology and Oral Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

出版信息

J Oral Pathol Med. 2021 Jul;50(6):540-547. doi: 10.1111/jop.13204. Epub 2021 Jun 24.

DOI:10.1111/jop.13204
PMID:34097773
Abstract

Immunosuppressed patients may be affected by a wide range of lymphoproliferative disorders (LPDs) ranging from self-limiting disorders to malignant lymphoid proliferations. These LPDs may be associated with systemic immune disorders, develop following organ transplantation or occur in the background of other forms of iatrogenic immunosuppression. Lymphotropic viruses, including Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV8), have been associated with the pathogenesis of distinct LPDs. The resulting classification of this group of disorders is very complex and inconsistent, with several new and emerging entities. Consequently, the diagnosis of an LPD, especially in an immunosuppressed patient, and its subsequent clinical management usually represent an important pitfall in daily clinical and pathology work. Therefore, the aim of this review was to use the available literature to describe the clinicopathological features of the most important benign LPDs that may be diagnosed in the head and neck region of immunosuppressed patients. Original clinical and microscopic images were used to illustrate some of these entities.

摘要

免疫抑制患者可能受到多种淋巴增殖性疾病(LPDs)的影响,范围从自限性疾病到恶性淋巴组织增生。这些 LPDs 可能与全身性免疫紊乱有关,在器官移植后发生或在其他形式的医源性免疫抑制背景下发生。淋巴亲嗜性病毒,包括 Epstein-Barr 病毒(EBV)和人类疱疹病毒-8(HHV8),与不同 LPDs 的发病机制有关。该组疾病的分类非常复杂且不一致,存在几种新出现的实体。因此,LPD 的诊断,特别是在免疫抑制患者中,以及随后的临床管理,通常是日常临床和病理工作中的一个重要陷阱。因此,本综述的目的是利用现有文献描述在免疫抑制患者的头颈部可能诊断出的最重要的良性 LPDs 的临床病理特征。使用原始的临床和显微镜图像来说明其中的一些实体。

相似文献

1
Benign lymphoproliferative disorders in the immunosuppressed patient: an update.免疫抑制患者的良性淋巴组织增生性疾病:最新进展。
J Oral Pathol Med. 2021 Jul;50(6):540-547. doi: 10.1111/jop.13204. Epub 2021 Jun 24.
2
Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.皮肤受限、甲氨蝶呤相关的 EBV 阳性黏膜溃疡——高度恶性淋巴瘤的一种类似物。4 例报告及文献复习。
Am J Dermatopathol. 2023 Aug 1;45(8):519-531. doi: 10.1097/DAD.0000000000002419.
3
Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder.伴有 HHV8 和 EBV 感染的淋巴组织增生性疾病:不仅仅是原发性渗出性淋巴瘤和生殖细胞性淋巴组织增生性疾病。
Histopathology. 2018 Apr;72(5):855-861. doi: 10.1111/his.13428. Epub 2018 Jan 3.
4
Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.EB 病毒再激活影响人类疱疹病毒 8 相关淋巴组织增生性疾病中的克隆进化。
Histopathology. 2021 Dec;79(6):1099-1107. doi: 10.1111/his.14551. Epub 2021 Oct 4.
5
How I Diagnose EBV-Positive B- and T-Cell Lymphoproliferative Disorders.我如何诊断EBV阳性的B细胞和T细胞淋巴增殖性疾病。
Am J Clin Pathol. 2023 Jan 4;159(1):14-33. doi: 10.1093/ajcp/aqac105.
6
Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.与自身免疫性疾病患者停用免疫抑制药物后病情缓解以及随后发生的医源性免疫缺陷相关淋巴组织增生性疾病进展相关的 Epstein-Barr 病毒。
Hematol Oncol. 2020 Dec;38(5):799-807. doi: 10.1002/hon.2790. Epub 2020 Aug 21.
7
Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.理解爱泼斯坦-巴尔病毒相关淋巴增殖性疾病发病机制的进展
Iran J Allergy Asthma Immunol. 2015 Oct;14(5):462-71.
8
Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?免疫缺陷相关淋巴组织增生性疾病:重新评估的时机?
Blood. 2018 Nov 1;132(18):1871-1878. doi: 10.1182/blood-2018-04-842559. Epub 2018 Aug 6.
9
Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemia.一名患B细胞急性淋巴细胞白血病儿童的医源性免疫缺陷相关淋巴增殖性疾病
Pediatr Hematol Oncol. 2019 Aug;36(5):309-316. doi: 10.1080/08880018.2019.1637982. Epub 2019 Jul 17.
10
Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.爱泼斯坦-巴尔病毒潜伏膜蛋白1癌基因缺失:与爱泼斯坦-巴尔病毒相关淋巴增殖性疾病及恶性淋巴瘤中恶性程度的相关性
Blood. 1996 Jul 1;88(1):242-51.

引用本文的文献

1
Prevalence of IgG antibodies against Malawi polyomavirus in patients with autoimmune diseases and lymphoproliferative disorders subjected to bone marrow transplantation.马拉维多瘤病毒 IgG 抗体在接受骨髓移植的自身免疫性疾病和淋巴增生性疾病患者中的流行率。
Front Immunol. 2024 Jan 17;14:1293313. doi: 10.3389/fimmu.2023.1293313. eCollection 2023.